Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Generative AI Solutions Corp C.AICO

Alternate Symbol(s):  AICOF

Generative AI Solutions Corp. is a Canada-based artificial intelligence company. The Company is focused on developing a vertically integrated artificial intelligence (AI) solutions business through its MAI Cloud platform, with the development and commercialization of AI-powered tools and solutions for businesses and consumers across multiple industries. It is focused on using AI to create... see more

CSE:AICO - Post Discussion

Generative AI Solutions Corp > march 16th 2022
View:
Post by podatlis1 on Mar 19, 2022 7:17am

march 16th 2022

U.S. President Joe Biden on Tuesday signed into law a spending bill that gives the Food and Drug Administration authority over synthetic nicotine.

The language of the Tobacco Control Act will now change to define a tobacco product as “any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption.”

The amendment comes into effect 30 days after the bill’s enactment. Manufacturers of products made with synthetic nicotine will then have an additional 30 days to submit a premarket tobacco product application (PMTA) to the FDA. If FDA has not authorized the product within 90 days after the effective date, the product must be removed from the market.

Comment by deepoil0808 on Mar 19, 2022 12:03pm
Poda started to process the PMTA in September 2021.  Takes 18 months for approval.
Comment by podatlis1 on Mar 19, 2022 12:45pm
guess i won`t hold my breath here in the u.s..for anything from poda anytime soon..thanks.deepoil
Comment by deepoil0808 on Mar 19, 2022 5:17pm
On the positive side of the PMTA it will ensure that only those companies that deliver nicotine in a manner which reduces exposure to future health issues will be approved.  Poda has enough scientific evidence to prove that their heat and not burn product which delivers nicotine is much safer than the competition that is out there. This Biden move will trigger a consolidation in the ...more  
Comment by Catspajamas on Mar 19, 2022 6:48pm
You'd be better off not lying Pinocchio, and not investing. Have you ever invested in anything that was successful? I thought not.
Comment by Catspajamas on Mar 20, 2022 3:15am
Go to the MEDV boards to see what a kook DeepOilyHiddenSecrets is! Bahahawawawawa!!!
Comment by podatlis1 on Mar 20, 2022 6:17am
Pursuant to the Consulting Agreement, NKO will help to coordinate and oversee the entire PMTA process for certain Poda products. It is anticipated that the entire PMTA process will take at least 18 months. Prior to receiving PMTA approval, however, Poda may be able to sell certain of its products in the USA that are not subject to PMTA authorization requirements.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities